. 2009 Oct;11(10):990–999. doi: 10.1093/eurjhf/hfp116

Table 3.

HERB CHF global assessment results

Outcome	Six month visit		P-value⁽¹⁾*	P-value⁽²⁾*
Outcome	Placebo, n (%)^a	Hawthorn, n (%)^a	P-value⁽¹⁾*	P-value⁽²⁾*
Patient global assessment			0.55	0.58
Markedly better	9 (16)	10 (19)
Moderately better	14 (25)	10 (19)
Mildly better	11 (20)	8 (15)
No change	17 (30)	18 (34)
Mildly worse	4 (7)	4 (8)
Moderately worse	1 (2)	3 (6)
Markedly worse	0 (0)	0 (0)
Physician global assessment			0.76	0.59
Markedly better	4 (7)	7 (13)
Moderately better	14 (25)	7 (13)
Mildly better	10 (18)	14 (26)
No change	22 (39)	14 (26)
Mildly worse	4 (7)	6 (11)
Moderately worse	1 (2)	2 (4)
Markedly worse	1 (2)	4 (7)

^aPercentages may not add up to 100 due to rounding of digits.

*P-value based on Wilcoxon rank-sum test comparing placebo to hawthorn at 3 months (1) or 6 months (2) after study entry. Ratings were converted to ordinal values from 1 (markedly worse) to 7 (markedly better) for calculation.